(688203)"ZHEJIANG HISUN BIOMATERIALS CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 688203 · · 12 pages · Chinese
Summary by 6ix AI
The report includes significant increases in revenue and net profit compared to the same period last year, indicating strong financial performance. The financial statements included in the report are unaudited, reflecting the company's performance for the first nine months of the year.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Zhejiang Hisun Biomaterials Co., Ltd. on 6ix
Earlier from Zhejiang Hisun Biomaterials
- (688203)"ZHEJIANG HISUN BIOMATERIALS CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Resolutions of the 1st Meeting of the 8th Board of Directors
- Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
- Announcement on Litigation Matters Involving Wholly-owned Subsidiary
Follow Zhejiang Hisun Biomaterials into a list and get an email when it puts out news.
Follow Zhejiang Hisun Biomaterials